RxDoctor Payments Data

Timothy Lesser, MD

Urology · Torrance, CANPI 1053436550

Payments from drug & device makers

$221,466in general payments, 2019–2025

Across 478 payments — averaging $463.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$207K
  • Neotract Inc.$2K
  • SN Holdings, LLC$1K
  • AbbVie$1K
  • Astellas Pharma US Inc$1K
  • Dendreon Pharmaceuticals LLC$837
  • plus $8K from 54 others

What the payments were for

  • Travel & lodging$1,2959%
  • Food & beverage$12,32787%
  • Education$5224%
  • Gifts$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC16$207,306
Neotract Inc.27$2,336
SN Holdings, LLC8$1,150
AbbVie(2 entities)55$1,135
Astellas Pharma US Inc38$1,049
Dendreon Pharmaceuticals LLC33$837
Biotissue Holdings Inc.18$672
Myriad Genetic Laboratories, Inc.26$616
Sumitomo Pharma America, Inc.21$471
Johnson & Johnson(2 entities)20$447
Bayer22$428
Axonics, Inc.8$362
Urogen Pharma, Inc.11$316
Teleflex LLC10$266
Procept Biorobotics Corporation7$261
Merck12$259
Telix Pharmaceuticals6$251
Pfizer14$232
Smith+Nephew10$202
Myovant Sciences Inc.6$170
Medtronic1$167
Boston Scientific8$165
Blue Earth Diagnostics6$164
Laborie Medical Technologies Corp.3$160
Endo Pharmaceuticals Inc.8$153
Progenics Pharmaceuticals, Inc.7$151
Otsuka America Pharmaceutical, Inc.3$143
Acerus Pharmaceuticals Corporation6$134
Bard Access Systems, Inc.1$100
Accord Healthcare, Inc.6$100
Immunitybio, Inc.3$73
Tolmar Pharmaceuticals, Inc.4$72
Urovant Sciences Inc3$72
Endo USA, Inc.3$68
Angiodynamics, Inc.2$59
Novartis2$58
Photocure Inc4$58
Amgen2$56
Stryker2$56
Metuchen Pharmaceuticals3$55
Ferring Pharmaceuticals Inc.3$53
Osiris Therapeutics Inc.3$48
180 Medical, Inc.2$47
Antares Pharma, Inc.3$46
EDAP Technomed Inc1$46
Amniox Medical, Inc.4$41
Baxter Healthcare1$41
Pacira Pharmaceuticals Incorporated1$39
Valencia Technologies Corporation1$36
Bluewind Medical1$29
Agiliti Surgical, Inc.2$28
Alnylam Pharmaceuticals Inc.1$27
Aytu Biopharma, Inc.1$23
Palette Life Sciences, Inc.1$23
Travere Therapeutics, Inc.1$22
Conmed Corporation1$22
E.r. Squibb & Sons, L.L.C.1$20
Profound Medical Corp.1$18
Coloplast1$14
Siemens Medical Solutions USA, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$221,466 in reported general payments places this provider in the 90th percentile of 1,324 urology providers in California.

See all urology providers in California

Medicare billing

Part B allowed, 2024
$787,542
Medicare patients
1,601
Services billed
29,114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron35$39,152
OrgovyxRelugolix13$35,933
MyrbetriqMirabegron27$23,025
Tamsulosin Hcl362$6,299
Finasteride202$3,645
Cefdinir80$1,467
Methenamine Hippurate11$1,460
Dutasteride35$1,369
Alfuzosin Hcl ErAlfuzosin Hcl44$1,055
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst51$738
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav60$585
Solifenacin Succinate15$383
Sildenafil Citrate35$370
Terazosin Hcl20$336
Bicalutamide19$263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa, Orgovyx$471$75,08548 claims
Astellas Pharma US IncMyrbetriq$1,049$23,02527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,324 urology providers in California.

Other urology in Torrance

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →